Africa is taking proactive steps to prepare for a potential mpox (monkeypox) vaccine rollout, aiming to avoid the mistakes made during the COVID-19 pandemic. The continent has learned valuable lessons from the pandemic and is working to ensure equitable access to vaccines, improve healthcare infrastructure, and enhance community engagement.
The African Union (AU) and the Africa Centers for Disease Control and Prevention (Africa CDC) are leading the efforts to develop a comprehensive mpox vaccine plan. The plan focuses on securing a fair share of vaccine doses, promoting vaccine acceptance, and addressing logistical challenges.
Unlike during the COVID-19 pandemic, where Africa was largely reliant on vaccine donations, the continent is now proactive in securing vaccine doses. The AU has already secured 110 million mpox vaccine doses, with more orders expected.
Additionally, African countries are investing in healthcare infrastructure, including vaccination centers, cold chain storage, and healthcare worker training. Community engagement and awareness campaigns are also underway to address vaccine hesitancy and promote acceptance.
The mpox vaccine plan is a testament to Africa’s determination to learn from past experiences and prepare for future pandemics. By prioritizing equitable access, healthcare infrastructure, and community engagement, Africa is taking a proactive approach to protect its citizens and prevent a repeat of the COVID-19 pandemic errors.